Suppr超能文献

利尿剂会增强血管紧张素转换酶抑制剂诱发的急性肾衰竭。

Diuretics potentiate angiotensin converting enzyme inhibitor-induced acute renal failure.

作者信息

Mandal A K, Markert R J, Saklayen M G, Mankus R A, Yokokawa K

机构信息

Department of Medicine, Department of Veterans Affairs Medical Center, Dayton, Ohio.

出版信息

Clin Nephrol. 1994 Sep;42(3):170-4.

PMID:7994935
Abstract

Previous studies suggest that angiotensin converting enzyme (ACE) inhibitors cause reversible acute renal failure (ARF) in patients with hypertension, congestive heart failure (CHF), and renal disease. These patients often receive diuretics concomitantly with ACE inhibitors. The purpose of this study was to examine whether ACE inhibitors alone produce ARF or whether they do so when used in combination with diuretics. The medical records of patients taking ACE inhibitors without or with diuretics were reviewed. Complete data from 74 patients were obtained and the data were analyzed. These 74 patients had a diagnosis of hypertension, CHF or diabetes mellitus. BUN and serum creatinine values before, during, and after discontinuation of ACE inhibitor therapy for a mean period of 8.7 months were collected. Seventy-four patients were divided into two groups: Group A (n = 41) patients who received ACE inhibitors alone; Group B (n = 33) patients who received a combination of an ACE inhibitor and a diuretic. ARF developed in 1 of 41 (2.4%) Group A patients compared to 11 of 33 (33%) Group B patients. This group difference was highly significant (P < .001). In Group A, mean serum creatinine before (1.24 +/- .34 mg/dl) was identical to that 1.23 +/- .33 mg/dl) after 8.7 months of ACE inhibitor therapy, whereas in Group B, post-mean serum creatinine (3.11 +/- 2.27 mg/dl) was significantly (P < .01) higher than pre-mean serum creatinine (1.65 +/- .85 mg/dl). CHF patients had a higher rate of ARF than patients with other diagnoses. Urinary electrolytes showed that 4 of 6 Group B patients had chloride concentration less than 20 mEq/l.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

既往研究表明,血管紧张素转换酶(ACE)抑制剂可导致高血压、充血性心力衰竭(CHF)及肾病患者出现可逆性急性肾衰竭(ARF)。这些患者常同时接受利尿剂和ACE抑制剂治疗。本研究旨在探讨单独使用ACE抑制剂是否会导致ARF,以及与利尿剂合用时是否会导致ARF。回顾了服用ACE抑制剂且未使用或使用了利尿剂的患者的病历。获取了74例患者的完整数据并进行分析。这74例患者被诊断为高血压、CHF或糖尿病。收集了在平均8.7个月的ACE抑制剂治疗前、治疗期间及停药后的血尿素氮(BUN)和血清肌酐值。74例患者分为两组:A组(n = 41)为单独接受ACE抑制剂治疗的患者;B组(n = 33)为接受ACE抑制剂与利尿剂联合治疗的患者。A组41例患者中有1例(2.4%)发生ARF,而B组33例患者中有11例(33%)发生ARF。两组差异具有高度显著性(P <.001)。在A组,ACE抑制剂治疗8.7个月后平均血清肌酐(1.23±.33mg/dl)与治疗前(1.24±.34mg/dl)相同,而在B组,治疗后平均血清肌酐(3.11±2.27mg/dl)显著高于治疗前(1.65±.85mg/dl)(P <.01)。CHF患者发生ARF的比例高于其他诊断的患者。尿电解质显示,B组6例患者中有4例氯化物浓度低于20mEq/l。(摘要截取自250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验